EMCDDA Home
  • EN

Youth and the schools population (EYE)

Statistics found here the category is Studies of youth and the schools population (EYE)

Category Title
EYE EYE-1. Cannabis prevalence rates Part (i) Lifetime, last year and last month prevalence of cannabis use among 15/16 year old school students (%), 2007
EYE EYE-1. Cannabis prevalence rates Part (ii) Lifetime prevalence of cannabis use among 15/16 year old school students (%), 1995, 1999, 2003 and 2007
EYE EYE-1. Cannabis prevalence rates Part (iii) Male and female lifetime prevalence of 40 or more cannabis uses among 15/16 year old school students (%), 2007
EYE EYE-1. Cannabis prevalence rates Part (iv) Current (last month) prevalence of cannabis use among 15/16 and 17/18 year old school students' (%), 2003
EYE EYE-1. Cannabis prevalence rates Part (v) Lifetime prevalence of cannabis use and perceived great risk among 15/16 year olds school students (%), 2007
EYE EYE-1. Cannabis prevalence rates Part (vi) Lifetime prevalence for cannabis and ecstasy use with easy availability among 15/16 school students (%), 2007
EYE EYE-1. Cannabis prevalence rates Part (vii) Reports of first use of cannabis aged 13 years or younger among 15/16 year old school students (%), 1999, 2003, 2007
EYE EYE-1. Cannabis prevalence rates Part (viii) Lifetime prevalence of cannabis use and drinking 5 or more drinks in a row during past month among 15/16 year old school students (%), 2007
EYE EYE-1. Cannabis prevalence rates Part (ix) Change in percentage lifetime prevalence of cannabis use among 15/16 year old school students, 1995-2007
EYE EYE-1. Cannabis prevalence rates Part (x) Change in percentage lifetime prevalence of cannabis use among 15/16 year old school students, 2003-2007
EYE EYE-1. Cannabis prevalence rates Part (xi) Trends in lifetime prevalence of cannabis use among 15- to 16-year-old school students: low prevalence countries, east and central European countries, west European countries, Slovenia and Croatia
EYE EYE-1. Cannabis prevalence rates Part (xii) Comparision of trends in average (weighted) lifetime prevalence of cannabis (%) among 15-16 year old school students in Europe, USA and Australia
EYE EYE-1. Cannabis prevalence rates Part (xiii) Trends in average (unweighted) lifetime prevalence of cannabis (%) among 15-16 year old school students in four country groups
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (i) Changes in lifetime prevalence of ecstasy use among 15/16 year old school students (%), 1995-2007
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (ii) Changes in lifetime prevalence of ecstasy use among 15/16 year old school students (%), 2003–07
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (iii) Lifetime prevalence of ecstacy use and perceived great risk among 15/16 year olds school (%), 2007
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (iv) Last month prevalence of drinking 5+ alcoholic drinks in a row and perceived great risk among 15/16 year olds school (%), 2007
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (v) Lifetime prevalence for use of ecstasy, LSD and other hallucinogens and magic mushrooms among 15/16 year old students (%), 2007
EYE EYE-2. Lifetime prevalence for drugs other than cannabis among school students Part (vi) Lifetime prevalence for use of ecstasy and amphetamines among 15/16 year old students (%), 2007
EYE EYE-0. School surveys: Sources
EYE EYE-10. Recent school surveys (2005–2008): percentage lifetime prevalence of psychoactive substance use among students aged 15–16 years old
EYE EYE-11. School surveys: percentage lifetime prevalence of psychoactive substance use among students aged 15–16 years
EYE EYE-20. ESPAD 2007 school surveys: percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (i) All students
EYE EYE-20. ESPAD 2007 school surveys: percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (ii) Males
EYE EYE-20. ESPAD 2007 school surveys:percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (iii) Females
EYE EYE-21. ESPAD 2007 school surveys: lifetime (LTP), last year (LYP) and last month (LMP) prevalence of cannabis use among students 15–16 years Part (i) All students
EYE EYE-21. ESPAD 2007 school surveys: lifetime (LTP), last year (LYP) and last month (LMP) prevalence of cannabis use among students 15–16 years Part (ii) Males
EYE EYE-21. ESPAD 2007 school surveys: lifetime (LTP), last year (LYP) and last month (LMP) prevalence of cannabis use among students 15–16 years Part (iii) Females
EYE EYE-22. All ESPAD school surveys: percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (i) All students
EYE EYE-22. All ESPAD school surveys: percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (ii) Males
EYE EYE-22. All ESPAD school surveys: percentage lifetime prevalence of psychoactive substance use among students 15–16 years Part (iii) Females
EYE EYE-23. All ESPAD school surveys: prevalence and patterns (percentages) of cannabis use among students 15–16 years Part (i) All students
EYE EYE-23. All ESPAD school surveys: prevalence and patterns (percentages) of cannabis use among students 15–16 years Part (ii) Males
EYE EYE-23. All ESPAD school surveys: prevalence and patterns (percentages) of cannabis use among students 15–16 years Part (iii) Females
EYE EYE-30. Recent school surveys (2003-2008): percentage lifetime prevalence of psychoactive substance use and last month prevalence of cannabis among students aged 17-18 years old

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 04 June 2010